Survival after the onset of congestive heart failure in Framingham Heart Study subjects

Circulation

Volumn 88, Issue 1, 1993, Pages 107-115

  Ho, Kalon K L ^a,b,c   Anderson, Keaven M ^c,d   Kannel, William B ^e   Grossman, William ^a,b   Levy, Daniel ^a,b,c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c FRAMINGHAM HEART STUDY   (United States)

^d CENTOCOR INC   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Congestive heart failure; Epidemiology; Mortality; Prognosis; Survival

Indexed keywords

ADULT; AGE; ARTICLE; CONGESTIVE HEART FAILURE; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE; VALVULAR HEART DISEASE;

AGE FACTORS; AGED; COHORT STUDIES; FEMALE; HEART FAILURE, CONGESTIVE; HUMAN; MALE; MASSACHUSETTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SEX FACTORS; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS;

EID: 0027210870     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.88.1.107     Document Type: Article

References (49)

1. National Center for Health Statistics. Mortality trends for leading causes of death: United States, 1950-69. National Vital Statistics System, series 20, No. 16. DHEW Publication No. (HRA) 74-1853. Washington, DC, US Government Printing Office, 1974.
2. Stern MP. The recent decline in ischemic heart disease mortality. Ann Intern Med. 1979;91:630-640.
3. National Center for Health Statistics. Mortality from diseases associated with smoking. National Vital Statistics System, series 20, No. 17. DHHS publication No. (PHS) 82-1854. Washington, DC, US Government Printing Office, 1982.
4. Centers for Disease Control. Chronic Disease Reports: Mortality trends - United States, 1979-1986. MMWR. 1989;38:189-191.
5. Centers for Disease Control. Mortality patterns - United States, 1987. MMWR. 1990;39:193-196, 201.
6. National Heart, Lung, and Blood Institute. Morbidity and mortality chartbook on cardiovascular, lung, and blood diseases, 1990. Bethesda, Md, US Department of Health and Human Services, 1990.
7. Goldman L, Cook EF. The decline in ischemic heart disease mortality rates. Ann Intern Med. 1984;101:825-836.
8. Dawber TR, Meadors GF, Moore FE. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health. 1951;41:279-286.
9. Dawber TR, Kannel WB, Lyell LP. An approach to longitudinal studies in a community: the Framingham Study. Ann N Y Acad Sci. 1963;107:539-556.
10. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families: the Framingham Offspring Study. Am J Epidemiol. 1979;110:281-290.
11. Shurtleff D. Some characteristics related to the incidence of cardiovascular disease and death: Framingham Study 18-year followup. In: Kannel WB, Gordon T, eds. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease, section 30. DHEW publication No. (NIH) 74-599. Washington, DC, US Government Printing Office, 1974; 17-35.
12. Cupples LA, D'Agostino RB. Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements: Framingham Heart Study, 30-year followup. In: Kannel WB, Wolf PA, Garrison RJ, eds. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease, section 34. DHHS publication No. (NIH) 87-2703. Washington, DC, US Government Printing Office, 1987; 12-19.
13. Abell LL, Levy BB, Brodie BB, Kendall FE. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem. 1952;195:357-366.
14. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham Study. N Engl J Med. 1971;285:1441-1446.
15. Cox DR. Regression models and life tables. J R Stat Soc [B]. 1972;34:187-220.
16. Fraumeni JF, Hoover RW, Devesa SS, Kinlen LJ. Epidemiology of cancer. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. Philadelphia, Pa, JB Lippincott, 1989;196-235.
17. Gillum RF. Heart failure in the United States 1970-1985. Am Heart J. 1987;113:1043-1045.
18. Glover DR, Littler WA. Factors influencing survival and mode of death in severe chronic ischaemic cardiac failure. Br Heart J. 1987; 57:125-132.
19. Koide T, Kato A, Takabatake Y, Iizuka M, Uchida Y, Ozeki K, Morooka S, Kakihana M, Serizawa T, Tanaka S, Ohya T, Momomura S, Murao S. Variable prognosis in congestive cardiomyopathy: role of left ventricular function, alcoholism, and pulmonary thrombosis. Jpn Heart J. 1980;21:451-463.
20. Massie B, Ports T, Chatterjee K, Parmley W, Ostland J, O'Young J, Haughom F. Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements. Circulation. 1981;63:269-278.
21. Wilson JR, Schwartz JS, St John Sutton M, Ferraro N, Horowitz LN, Reichek N, Josephson ME. Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol. 1983;2:403-410.
22. Unverferth DV, Magorien RD, Moeschberger ML, Baker PB, Fetters JK, Leier CV. Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol. 1984;54:147-152.
23. Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol. 1987;59:634-638.
24. Matoba M, Matsui S, Hirakawa T, Aoyama T, Takeda F, Asaji T, Doyousita H, Enyama H, Fukuoka T, Nakatou H, Emoto J, Takekoshi N, Murakami E. Long-term prognosis of patients with congestive heart failure. Jpn Circ J. 1990;54:57-61.
25. Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol. 1981;47:525-531.
26. Kelly TL, Cremo R, Nielsen C, Shabetai R. Prediction of outcome in late-stage cardiomyopathy. Am Heart J. 1990;119:1111-1121.
27. Franciosa JA, Wilen M, Ziesche S, Conn JN. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol. 1983; 51:831-836.
28. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823.
29. Cleland JGF, Dargie HJ, Ford I. Mortality in heart failure: clinical variables of prognostic value. Br Heart J. 1987;58:572-582.
30. Conn JN, Archibald DG, Francis GS, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Flohr KH, Goldman S, Cobb FR, Shah PM, Saunders R, Fletcher RD, Loeb HS, Hughes VC, Baker B. Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of pre-randomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate. Circulation. 1987; 75(suppl IV):IV-49-IV-54.
31. Kjekshus J, Swedberg K. Enalapril for congestive heart failure. Am J Cardiol. 1989;63(suppl D):26D-32D.
32. Gradman A, Deedwania P, Cody R, Massie B, Packer M, Pitt B, Goldstein S. Predictors of total mortality and sudden death in mild to moderate heart failure. J Am Coll Cardiol. 1989;14:564-570.
33. Fonarow GC, Chelimsky-Fallick C, Stevenson LW, Luu M, Hamilton MA, Moriguchi JD, Tillisch JH, Walden JA, Albanese E. Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C Trial. J Am Coll Cardiol. 1992; 19:842-850.
34. Burggraf GW, Parker JO. Prognosis in coronary artery disease: angiographic, hemodynamic, and clinical factors. Circulation. 1975; 51:146-156.
35. Conn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH, Goldman S, Cobb FR, Shah PM, Saunders R, Fletcher RD, Loeb HS, Hughes VC, Baker B. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N Engl J Med. 1986;314:1547-1552.
36. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M, Bhat G, Goldman S, Fletcher RD, Doherty J, Hughes CV, Carson P, Cintron G, Shabetai R, Haakenson C. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325:303-310.
37. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham Study. JAMA. 1979;241:2035-2038.
38. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham Study. Diabetes Care. 1979;2:120-126.
39. Galderisi M, Anderson KM, Wilson PWF, Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol. 1991;68:85-89.
40. Marantz PR, Tobin JN, Wassertheil-Smoller S, Steingart RM, Wexler JP, Budner N, Lense L, Wachspress J. The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria. Circulation. 1988;77:607-612.
41. Dougherty AH, Naccarelli GV, Gray EL, Hicks CH, Goldstein RA. Congestive heart failure with normal systolic function. Am J Cardiol. 1984;54:778-782.
42. Grossman W. Diastolic dysfunction in congestive heart failure: mechanisms and clinical implications. N Engl J Med. 1991;325:1557-1564.
43. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
44. Soufer R, Wohlgelernter D, Vita NA, Amuchestegui M, Sostman HD, Berger HJ, Zaret BL. Intact systolic left ventricular function in clinical congestive heart failure. Am J Cardiol. 1985;55:1032-1036.
45. Echeverria HH, Bilsker MS, Myerburg RJ, Kessler KM. Congestive heart failure: echocardiographic insights. Am J Med. 1983;75:750-755.
46. Aguirre FV, Pearson AC, Lewen MK, McCluskey M, Labovitz AJ. Usefulness of Doppler echocardiography in the diagnosis of congestive heart failure. Am J Cardiol. 1989;63:1098-1102.
47. Wong WF, Gold S, Fukuyama O, Blanchette PL. Diastolic dysfunction in elderly patients with congestive heart failure. Am J Cardiol. 1989;63:1526-1528.
48. Cohn JN, Johnson G. Heart failure with normal ejection fraction: the V-HeFT Study. Circulation. 1990;81(suppl III):III-48-III-53.
49. Setaro JF, Soufer R, Remetz MS, Perlmutter RA, Zaret BL. Long-term outcome in patients with congestive heart failure and intact systolic left ventricular performance. Am J Cardiol. 1992;69:1212-1216.